Načítá se...

FoxM1 Mediates Resistance to Herceptin and Paclitaxel

Inherent and acquired therapeutic resistance in breast cancer remains a major clinical challenge. In human breast cancer samples, overexpression of the oncogenic transcription factor FoxM1 has been suggested to be a marker of poor prognosis. In this study, we report that FoxM1 overexpression confers...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Carr, Janai R., Park, Hyun Jung, Wang, Zebin, Kiefer, Megan M., Raychaudhuri, Pradip
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2893542/
https://ncbi.nlm.nih.gov/pubmed/20530690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-0545
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!